RS
EVH icon

R Squared’s Evolent Health EVH Stock Holding History

R Squared’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.6K Buy
+11,206
New +$35.5K 0.01% 452
2025
Q1 		– Sell
-2,760
Closed -$31.1K – 680
2024
Q4 		$31.1K Buy
+2,760
New +$48.5K 0.03% 686

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's EVH Position: Q1 2026 in Review

R Squared opened a new position in Evolent Health (EVH) in Q1 2026: 11,206 shares worth $25.6K. The stake represents 0.01% of the portfolio and ranks #452 among its holdings. This is a return to the name: R Squared previously reported a position in EVH as recently as Q4 2024.

R Squared first reported a position in EVH in Q4 2024 and has held it in 2 quarters since. The position peaked at $31.1K in Q4 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • R Squared held 11,206 shares of Evolent Health worth $25.6K as of Q1 2026.
  • Evolent Health was a new R Squared position in Q1 2026.
  • Evolent Health made up 0.01% of R Squared's portfolio in Q1 2026, its #452 holding.
  • R Squared first reported a position in Evolent Health in Q4 2024 and has held it in 2 quarters since.
  • R Squared's Evolent Health position peaked at $31.1K in Q4 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.